Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125221941 | 12522194 | 1 | I | 20160509 | 20160622 | 20160701 | 20160701 | EXP | FR-TAKEDA-2016TUS011144 | TAKEDA | 91.00 | YR | F | Y | 0.00000 | 20160701 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125221941 | 12522194 | 1 | PS | Adenuric | FEBUXOSTAT | 1 | Oral | UNK | Y | 21856 | TABLET | ||||||||
125221941 | 12522194 | 2 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | UNK | Y | 0 | |||||||||
125221941 | 12522194 | 3 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | UNK | Y | 0 | |||||||||
125221941 | 12522194 | 4 | SS | COLCHIMAX /01722001/ | COLCHICINEOPIUMTIEMONIUM METHYLSULFATE | 1 | Oral | UNK | Y | 0 | TABLET | ||||||||
125221941 | 12522194 | 5 | SS | COLCHIMAX /01722001/ | COLCHICINEOPIUMTIEMONIUM METHYLSULFATE | 1 | Unknown | UNK | Y | 0 | TABLET | ||||||||
125221941 | 12522194 | 6 | C | AERIUS | DESLORATADINE | 1 | Oral | UNK | U | 0 | |||||||||
125221941 | 12522194 | 7 | C | DIFFU K | POTASSIUM CHLORIDE | 1 | Oral | UNK | U | 0 | |||||||||
125221941 | 12522194 | 8 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Oral | UNK | U | 0 | |||||||||
125221941 | 12522194 | 9 | C | KARDEGIC | ASPIRIN LYSINE | 1 | Oral | 75 MG, QD | U | 0 | 75 | MG | QD | ||||||
125221941 | 12522194 | 10 | C | DOLIPRANE | ACETAMINOPHEN | 1 | Oral | UNK | U | 0 | |||||||||
125221941 | 12522194 | 11 | C | EUPRESSYL /00631801/ | URAPIDIL | 1 | Oral | UNK | U | 0 | |||||||||
125221941 | 12522194 | 12 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125221941 | 12522194 | 1 | Product used for unknown indication |
125221941 | 12522194 | 2 | Product used for unknown indication |
125221941 | 12522194 | 4 | Product used for unknown indication |
125221941 | 12522194 | 6 | Product used for unknown indication |
125221941 | 12522194 | 7 | Product used for unknown indication |
125221941 | 12522194 | 8 | Product used for unknown indication |
125221941 | 12522194 | 9 | Product used for unknown indication |
125221941 | 12522194 | 10 | Product used for unknown indication |
125221941 | 12522194 | 11 | Product used for unknown indication |
125221941 | 12522194 | 12 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125221941 | 12522194 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125221941 | 12522194 | Eosinophilia | |
125221941 | 12522194 | Pruritus | |
125221941 | 12522194 | Rash maculo-papular |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125221941 | 12522194 | 1 | 20160521 | 0 | ||
125221941 | 12522194 | 2 | 20160312 | 0 | ||
125221941 | 12522194 | 3 | 20160419 | 20160602 | 0 | |
125221941 | 12522194 | 4 | 20160317 | 201603 | 0 | |
125221941 | 12522194 | 5 | 20160501 | 20160521 | 0 | |
125221941 | 12522194 | 6 | 20160602 | 0 | ||
125221941 | 12522194 | 7 | 20160602 | 0 | ||
125221941 | 12522194 | 8 | 20160602 | 0 | ||
125221941 | 12522194 | 9 | 20160605 | 0 |